Biomarkers of inflammation, endothelial dysfunction and insulin resistance in adults of Inner Mongolia, China

Diabetes/Metabolism Research and Reviews

Volumn 26, Issue 6, 2010, Pages 490-495

  Wang, Guiyan ^a,b   Liu, Yanbin ^a   Wang, Aili ^a   Tong, Weijun ^a   Zhang, Yonghong ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b Xiamen Maternity and Child Health Care Hospital   (China)

Author keywords

Endothelial dysfunction; Inflammation; Insulin resistance

Indexed keywords

ANGIOTENSIN II; BIOLOGICAL MARKER; C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLUCOSE; INSULIN; INTERCELLULAR ADHESION MOLECULE 1;

ADULT; ARTICLE; BLOOD SAMPLING; CHINA; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHINA; CROSS-SECTIONAL STUDIES; E-SELECTIN; ENDOTHELIUM, VASCULAR; HOMEOSTASIS; HUMANS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; INTERCELLULAR ADHESION MOLECULE-1; MIDDLE AGED;

EID: 77956642755     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.1108     Document Type: Article

References (31)

1. Stern SE, Williams K, Ferrannini E, DeFronzo RA, Bogardus C, Stern MP. Identification of individuals with insulin resistance using routine clinical measurements. Diabetes 2005; 54: 333-339. [PubMed: 15677489].
2. Abbasi F, Brown BW Jr, Lamendola C, McLaughlin T, Reaven GM. Relationship between obesity, insulin resistance, and coronary heart disease risk. J Am Coll Cardiol 2002; 40: 937-943. [PubMed: 12225719].
3. Hak AE, Pols HA, Stehouwer CD, et al. Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: the Rotterdam study. J Clin Endocrinol Metab 2001; 86: 4398-4405. [PubMed: 11549682].
4. Carantoni M, Abbasi F, Warmerdam F, et al. Relationship between insulin resistance and partially oxidized LDL particles in healthy, nondiabetic volunteers. Arterioscler Thromb Vasc Biol 1998; 18: 762-767. [PubMed: 9598835].
5. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930-1935. [PubMed: 11344187].
6. Peter K, Nawroth P, Conradt C, et al. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler Thromb Vasc Biol 1997; 17: 505-512. [PubMed: 9102169].
7. Anuurad E, Tracy RP, Pearson TA, Kim K, Berglund L. Synergistic role of inflammation and insulin resistance as coronary artery disease risk factors in African Americans and Caucasians. Atherosclerosis 2009; 205: 290-295. [PubMed: 19135196].
8. Zhang Y, Thompson AM, Tong W, et al. Biomarkers of inflammation and endothelial dysfunction and risk of hypertension among Inner Mongolians in China. J Hypertens 2010; 28: 35-40. [PubMed: 19770776].
9. Park K, SteffesM, Lee DH, Himes JH, Jacobs DR Jr. Association of inflammation with worsening HOMA-insulin resistance. Diabetologia 2009; 52: 2337-2344. [PubMed: 19680627].
10. Chen NG, Holmes M, Reaven GM. Relationship between insulin resistance, soluble adhesion molecules, and mononuclear cell binding in healthy volunteers. J Clin Endocrinol Metab 1999; 84: 3485-3489. [PubMed: 10522984].
11. Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation 2004; 109: II2-II10. [PubMed: 15173056].
12. Libby P, Ridker PM. Inflammation and atherothrombosis: from population biology and bench research to clinical practice. J Am Coll Cardiol 2006; 48(Suppl 1): A33-A46.
13. Li H, Xu T, Tong W, Liu Y, Zhao L, Zhang Y. Comparison of cardiovascular risk factors between prehypertension and hypertension in a Mongolian population, Inner Mongolia, China. Circ J 2008; 72: 1666-1673. [PubMed: 18753701].
14. Bei-Fan Z, Cooperative Meta-analysis Group of the Work Group on Obesity in China. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults: study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Asia Pac J Clin Nutr 2002; 11: S685-S693. [PubMed: 12534691].
15. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502. [PubMed: 4337382].
16. Haber E, Koerner T, Page LB, Kliman B, Purnode A. Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab 1969; 29: 1349-1355. [PubMed: 4311082].
17. Ridker PM. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol 2007; 49: 2129-2138. [PubMed: 17531663].
18. Emanuel RL, Cain JP, Williams GH. Double antibody radioimmunoassay of renin activity and angiotensin II in human peripheral plasma. J Lab Clin Med 1973; 81: 632-640. [PubMed: 4348744].
19. Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degree of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23: 57-63. [PubMed: 10857969].
20. Ridker PM, Wilson PW, Grundy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 2004; 109: 2818-2825. [PubMed: 15197153].
21. Rutter MK, Meigs JB, Sullivan LM, D' Agostino RB Sr, Wilson PW. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 2004; 110: 380-385. [PubMed: 15262834].
22. Kressel G, Trunz B, Bub A, et al. Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk. Atherosclerosis 2009; 202: 263-271. [PubMed: 18501910].
23. Gearing AJ, Newman W. Circulating adhesion molecules in disease. Immunol Today 1993; 14: 506-512. [PubMed: 7506035].
24. Szmitko PE, Wang CH, Weisel RD, de Almeida JR, Anderson TJ, Verma S. New markers of inflammation and endothelial cell activation, part I. Circulation 2003; 108: 1917-1923. [PubMed: 14568885].
25. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102: 2165-2168. [PubMed: 11056086].
26. Matsumoto K, Fujishima K, Moriuchi A, Saishoji H, Ueki Y. Soluble adhesion molecule E-selectin predicts cardiovascular events in Japanese patients with type 2 diabetes mellitus. Metabolism 2010; 59: 320-324. [PubMed: 20004427].
27. Schiffrin EL, Touyz RM. Multiple actions of angiotensin II in hypertension: benefits of AT 1 receptor blockade. J Am Coll Cardiol 2003; 42: 911-913. [PubMed: 12957442].
28. Pastore L, Tessitore A, Martinotti S, et al. Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo. Circulation 1999; 100: 1646-1652. [PubMed: 10517737].
29. Dzau VJ. Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension 2001; 37: 1047-1052. [PubMed: 11304501].
30. Liao TD, Yang XP, Liu YH, et al. Role of inflammation in the development of renal damage and dysfunction in angiotensin II-induced hypertension. Hypertension 2008; 52: 256-263. [PubMed: 18541733].
31. Mavri A, Stegnar M, Krebs M, Sentocnik JT, Geiger M, Binder BR. Impact of adipose tissue on plasma plasminogen activator inhibitor-1 in dieting obese women. Arterioscler Thromb Vasc Biol 1999; 19: 1582-1587.[PubMed: 10364094].